Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 49Rectal Neoplasms 26Colonic Neoplasms 23Pancreatic Neoplasms 19Neoplasm Metastasis 17Neoplasms 13Stomach Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Esophageal Neoplasms 6Osteosarcoma 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Burkitt Lymphoma 5Myelodysplastic Syndromes 4Gallbladder Neoplasms 4Adenocarcinoma Of Esophagus 4Triple Negative Breast Neoplasms 3Sarcoma 3Melanoma 3Lymphoma 3Lung Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Bile Duct Neoplasms 3Somatostatinoma 2

Interventions

Octreotide 3Irinotecan 2cabazitaxel 1XRP6258 1Theophylline 1Surveys and Questionnaires 1Sugars 1Prednisone 1PHY 906 1Leucovorin 1Lapatinib 1Fluorouracil 1Erlotinib Hydrochloride 1Endoscopy 1Drugs, Investigational 1Capecitabine 1Calcium Aluminosilicate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Diarrhea × Leucovorin × Clear all
NCT00040391 2016-12-01

A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

Celgene Corporation

Phase 2 Terminated
Gastrointestinal

Diarrhea, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡